An analysis of the expression of the histocompatibility antigens in the livers of patients with chronic hepatitis B virus infection and normal subjects has demonstrated an increased expression of HLA-A,B,C antigens on the hepatocytes of patients with a low level of viral replication (HBe antibody po
Correlation of preS antigens and clinical status during chronic hepatitis B virus infection
β Scribed by G. Taliani; M. Rapicetta; D. Francisci; J. Xiang; B. Sarrecchia; C. Bac; G. Stagni
- Book ID
- 104661765
- Publisher
- Springer-Verlag
- Year
- 1991
- Tongue
- English
- Weight
- 546 KB
- Volume
- 180
- Category
- Article
- ISSN
- 0300-8584
No coin nor oath required. For personal study only.
β¦ Synopsis
The serum kinetics of preS 1 and preS2 antigens has been evaluated in 38 serial samples from eight patients with chronic active (CAH) or chronic persistent (CPH) hepatitis, followed for 2-7 years (mean 4.4 years) in whom liver biopsy was performed at intervals, and in 46 samples from ten asymptomatic HBsAg carriers followed for 4-5 years (mean 4.6 years). Four patterns ofpreS behaviour have been observed: (1) persistently positive preS 1 and preS2; (2) disappearance of preS2;
(3) disappearance of both preS 1 and preS2; and (4) persistently negative preS 1 and preS2. Pattern 4 has been observed exclusively among healthy carriers, while seven out of eight chronic patients exhibited either pattern 1 or 2. Among the chronic patients, preS2 disappearance was accompanied or followed by alanine aminotransferase (ALT) normalization. The correlation of preS antigens with conventional viral replication markers showed that 100% of hepatitis B virus (HBV)-DNA-positive and 86.6% of HBeAg-positive sera were preS1/preS2 positive, while 61% of HBV-DNA-negative and 64 % of HBeAg-negative sera were preS1/preS2 negative. Our data suggest that continuous monitoring of preS antigens in follow-up sera will allow for an improved prognostic evaluation of chronic HBV infection.
π SIMILAR VOLUMES
The expression of the preSl antigen of hepatitis B virus in sera from chronic HBsAg carriers was studied using a specific monoclonal antibody F35.25 in an original, double-immunoradiometric assay. The antibody F35.25 recognized an epitope located between amino-acid residues 32 and 53 on the preSl se
This paper has been presented in part at the Meeting of the European Association for the Study of the Liver,